Clicky

Bausch Health Companies Inc.(BHC)

Description: Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Keywords: Biotechnology Life Sciences Laser Pharmaceutical Products Organ Systems S&P/Tsx 60 Index Medical Device Health Products Eye Psoriasis Dermatology Ulcer Ulcerative Colitis Acne Gastrointestinal Specialty Drugs Atopic Dermatitis Dermatitis Gastroenterology Diarrhea Colitis Contact Lens Over The Counter Products Hair Removal Irritable Bowel Syndrome Generic Pharmaceuticals Wrinkle Actinic Keratosis Generic Pharmaceutical Keratosis Aesthetic Medical Devices Bausch Health Dermatology Products Eye Health Products Hepatic Encephalopathy Dermatoses

Home Page: www.bauschhealth.com

BHC Technical Analysis

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
Phone: 514-744-6792


Officers

Name Title
Mr. Thomas J. Appio CEO & Director
Mr. Thomas G. Vadaketh Exec. VP & CFO
Mr. Mirza Dautbegovic Sr. VP & COO
Mr. John S. Barresi Sr. VP, Controller & Chief Accounting Officer
Dr. Robert F. Butz VP of Medical & Scientific Affairs
Mr. Arthur J. Shannon Sr. VP and Head of Investor Relations & Global Communications
Ms. Seana Carson Exec. VP & Gen. Counsel
Ms. Kathleen Fitzpatrick Sr. VP & Chief HR Officer
Dr. Tage Ramakrishna M.D. Chief Medical Officer and Pres of R&D
Mr. Jeff Hartness Sr. VP of Market Access, Commercial Operations & Gov. Affairs

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 2.0781
Trailing PE: 10.6338
Price-to-Book MRQ: 18.7773
Price-to-Sales TTM: 0.3442
IPO Date: 1994-03-29
Fiscal Year End: December
Full Time Employees: 19600
Back to stocks